Home›Companies›Healthcare›Vicora

Vicora, Inc.

Develops a device to help clinicians remove blood clots.

Updated Nov 9, 2026·Latest SEC filing Sep 18, 2026·Suggest an edit

About Vicora

Vicora is a private company based in Buffalo, New York. It has reported $5,700,000 raised in two offerings on Form D since October 2025. Its chief executive is Shawn Patterson.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 1, 2026Sep 18, 2026$2,300,000of $2.5M target59$38,983EquityRule 506(b)Form D ↗
Jan 31, 2025Oct 20, 2025$3,400,000of $6.0M target55$61,818EquityRule 506(b)Form D ↗
Total, two offerings$5,700,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Vicora's Form D filed Sep 18, 2026.

MC
Matthew Colpoys
Chief Financial Officer and director
RD
Richard Ducharme
Executive officer and director

Sources

  1. SECVicora, Inc. filing history
  2. ResearchGeorgia Tech industry talk